Coya Therapeutics, Inc./$COYA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Coya Therapeutics, Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Ticker
$COYA
Sector
Primary listing
Employees
8
Headquarters
Website
COYA Metrics
BasicAdvanced
$137m
-
-$1.16
0.55
-
Price and volume
Market cap
$137m
Beta
0.55
52-week high
$7.75
52-week low
$3.71
Average daily volume
171k
Financial strength
Current ratio
15.018
Quick ratio
14.303
Profitability
EBITDA (TTM)
-20.196
Gross margin (TTM)
-96.71%
Net profit margin (TTM)
-266.11%
Operating margin (TTM)
-254.68%
Effective tax rate (TTM)
-0.01%
Revenue per employee (TTM)
$990,000
Management effectiveness
Return on assets (TTM)
-27.57%
Return on equity (TTM)
-51.31%
Valuation
Price to revenue (TTM)
13.442
Price to book
2.81
Price to tangible book (TTM)
2.81
Price to free cash flow (TTM)
-6.6
Free cash flow yield (TTM)
-15.15%
Free cash flow per share (TTM)
-0.888
Growth
Revenue change (TTM)
115.44%
Earnings per share change (TTM)
7.00%
3-year earnings per share growth (CAGR)
-27.44%
COYA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs